| 利用者成果(英) |
|
19817
Miyata S, Ishii T, Kitanaka S.
Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia
Anticancer Res
2024
44(1):49-59
PubMed ID: 38159998
DOI: 10.21873/anticanres.16787
|
|
19848
Yamanaka T, Araki K, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Ishii N, Tsukagoshi M, Watanabe A, Harimoto N, Masamune A, Uojima H, Mizokami M, Ito K, Shirabe K.
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer
Cancer Sci
2024
Feb 6
PubMed ID: 38321872
DOI: 10.1111/cas.16087
|
|
21666
Zhang Z, Aoki H, Umezawa K, Kranrod J, Miyazaki N, Oshima T, Hirao T, Miura Y, Seubert J, Ito K, Aoki S.
Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells.
Cell Death Discov
2024
10(1):166
PubMed ID: 38580661
DOI: 10.1038/s41420-024-01933-4
|
|
21692
Tazuma S, Sudo T, Ishikawa A, Yamaguchi A, Shibata Y, Ishida Y, Kuraoka K, Uemura K, Takahashi S, Tashiro H.
Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.
Surg Today
2024
PubMed ID: 38637344
DOI: 10.1007/s00595-024-02824-y
|
|
21722
Zhong P, Nakata K, Oyama K, Higashijima N, Sagara A, Date S, Luo H, Hayashi M, Kubo A, Wu C, He S, Yamamoto T, Koikawa K, Iwamoto C, Abe T, Ikenaga N, Ohuchida K, Morisaki T, Oda Y, Kuba K, Nakamura M.
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
J Exp Clin Cancer Res
2024
43(1):138
PubMed ID: 38715057
DOI: 10.1186/s13046-024-03060-5
|
|
21802
Akimoto T, Islam MR, Nagasako A, Kishi K, Nakakaji R, Ohtake M, Hasumi H, Yamaguchi T, Yamada S, Yamamoto T, Ishikawa Y, Umemura M.
Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming.
Cancer Sci
2024
PubMed ID: 38877783
DOI: 10.1111/cas.16243
|
|
21897
Takata T, Nakamura A, Yasuda H, Miyake H, Sogame Y, Sawai Y, Hayakawa M, Mochizuki K, Nakao R, Ogata T, Ikoma H, Konishi E, Harada Y, Otsuji E, Itoh Y, Tanaka H.
Pathophysiological Implications of Protein Lactylation in Pancreatic Epithelial Tumors
Acta Histochem Cytochem
2024
57(2):57-66
PubMed ID: 38695038
DOI: 10.1267/ahc.24-00010
|
|
21916
Kiichi Y, Fukuoka K, Kitano A, Ishino K, Kotoku N.
Unified Synthesis and Biological Evaluation of Makaluvamine J and Its Analogs
Molecules
2024
29(6):1389
PubMed ID: 38543025
DOI: 10.3390/molecules29061389
|
|
22062
Terai T, Nishiwada S, Nagai M, Nakamura K, Kohara Y, Yasuda S, Matsuo Y, Doi S, Sakata T, Kumada H, Watanabe M, Sho M.
Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.
Pancreatology
2024
24(6):938-946
PubMed ID: 39152081
DOI: 10.1016/j.pan.2024.08.003
|
|
22131
Kawataki S, Kubota Y, Katayama K, Imoto S, Takekawa M.
GADD45β-MTK1 signaling axis mediates oncogenic stress-induced activation of the p38 and JNK pathways.
Cancer Sci
2024
PubMed ID: 39526327
DOI: 10.1111/cas.16389
|
|
18285
Yamakawa K, Koyanagi-Aoi M, Machinaga A, Kakiuchi N, Hirano T, Kodama Y, Aoi T.
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
Cancer Cell Int
2023
23(1):94
PubMed ID: 37198667
DOI: 10.1186/s12935-023-02928-4
|
|
19616
Masuo H, Kubota K, Shimizu A, Notake T, Miyazaki S, Yoshizawa T, Sakai H, Hayashi H, Soejima Y.
Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines
Cancer Sci
2023
114(11):4388-4400
PubMed ID: 37700464
DOI: 10.1111/cas.15962
|
|
19617
Kashiwagi R, Funayama R, Aoki S, Matsui A, Klein S, Sato Y, Suzuki T, Murakami K, Inoue K, Iseki M, Masuda K, Mizuma M, Naito H, Duda DG, Unno M, Nakayama K.
Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment
Cancer Sci
2023
114(11):4286-4298
PubMed ID: 37688308
DOI: 10.1111/cas.15952
|
|
19678
Fujihashi Y, Jo Kim M, Maneenet J, Awale S.
Piper longum Constituents Induce PANC-1 Human Pancreatic Cancer Cell Death under Nutrition Starvation
Chem Biodivers
2023
20(9):e202300280
PubMed ID: 37612242
DOI: 10.1002/cbdv.202300280
|
|
19693
Batbayar C, Ishii N, Harimoto N, Yokobori T, Saito H, Gantumur D, Gombodorj N, Erkhem-Ochir B, Muranushi R, Hoshino K, Yamanaka T, Hagiwara K, Tsukagoshi M, Watanabe A, Araki K, Hosouchi Y, Shirabe K.
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer
Int J Clin Oncol
2023
28(7):901-912
PubMed ID: 37119370
DOI: 10.1007/s10147-023-02342-w
|
|
19793
Tomohara K, Maneenet J, Ohashi N, Nose T, Fujii R, Kim MJ, Sun S, Awale S.
Ugi Adducts as Novel Anti-austerity Agents against PANC-1 Human Pancreatic Cancer Cell Line: A Rapid Synthetic Approach
Biol Pharm Bull
2023
46(10):1412-1420
PubMed ID: 37779042
DOI: 10.1248/bpb.b23-00224
|
|
21009
Doi Y, Wakana D, Kitaoka S, Sato F, Tanaka E, Takeda H, Hosoe T.
Ergot alkaloids in sclerotia collected in Japan: synthetic profiles and induction of apoptosis by Clavine-type compounds.
J Nat Med
2023
PubMed ID: 36635416
DOI: 10.1007/s11418-022-01673-8
|
|
21044
Yamada T, Tateishi R, Iwai M, Tanaka M, Ijichi H, Sano M, Koike K, Todo T.
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.
Mol Ther Oncolytics
2023
28:31-43
PubMed ID: 36619294
DOI: 10.1016/j.omto.2022.12.001
|
|
21057
Masuda M, Asuka T, Terao N, Nishino S, Ikeda S, Takamatsu S, Kondo J, Miyoshi E.
Establishment of a novel 70K Mac-2 binding protein antibody through screening of fucosylation-related antibodies.
J Biochem
2023
PubMed ID: 36760066
DOI: 10.1093/jb/mvad015
|
|
21107
Phan ND, Omar AM, Takahashi I, Baba H, Okumura T, Imura J, Okada T, Toyooka N, Fujii T, Awale S.
Nicolaioidesin C: An Antiausterity Agent Shows Promising Antitumor Activity in a Pancreatic Cancer Xenograft Mouse Model.
J Nat Prod
2023
PubMed ID: 36938707
DOI: 10.1021/acs.jnatprod.3c00019
|
|
21138
Xie L, Zhang L, Hu K, Hanyu M, Zhang Y, Fujinaga M, Minegishi K, Ohkubo T, Nagatsu K, Jiang C, Shimokawa T, Ashisuke K, Okonogi N, Yamada S, Wang F, Wang R, Zhang MR.
A 211At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy.
Cell Rep Med
2023
PubMed ID: 37003259
DOI: 10.1016/j.xcrm.2023.100960
|
|
21177
Ouchida T, Maeda H, Akamatsu Y, Maeda M, Takamatsu S, Kondo J, Misaki R, Kamada Y, Ueda M, Ueda K, Miyoshi E.
The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro.
Sci Rep
2023
13(1):6175
PubMed ID: 37061516
DOI: 10.1038/s41598-023-28572-6
|
|
21197
Ando H, Eshima K, Ishida T.
A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrest.
Eur J Pharmacol
2023
950:175758
PubMed ID: 37121563
DOI: 10.1016/j.ejphar.2023.175758
|
|
21234
Awale S, Baba H, Phan ND, Kim MJ, Maneenet J, Sawaki K, Kanda M, Okumura T, Fujii T, Okada T, Maruyama T, Okada T, Toyooka N.
Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, In Vitro and In Vivo Evaluation.
J Med Chem
2023
PubMed ID: 37257133
DOI: 10.1021/acs.jmedchem.3c00394
|
|
21257
Fukuda K, Seki N, Yasudome R, Mitsueda R, Asai S, Kato M, Idichi T, Kurahara H, Ohtsuka T.
Coronin 1C, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma.
Genes (Basel)
2023
14(5)
PubMed ID: 37239355
DOI: 10.3390/genes14050995
|
|
21290
Yamashita M, Kumazoe M, Onda H, Hiroi S, Shimada Y, Fujimura Y, Tachibana H.
PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer.
Biochem Biophys Res Commun
2023
672:154-160
PubMed ID: 37354608
DOI: 10.1016/j.bbrc.2023.06.043
|
|
21299
Sekiya S, Fukuda J, Yamamura R, Ooshio T, Satoh Y, Kosuge S, Sato R, Hatanaka KC, Hatanaka Y, Mitsuhashi T, Nakamura T, Matsuno Y, Hirano S, Sonoshita M.
Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.
Cancer Res
2023
OF1-OF12
PubMed ID: 37378549
DOI: 10.1158/0008-5472.CAN-22-3762
|
|
21412
Kitamura F, Semba T, Yasuda-Yoshihara N, Yamada K, Nishimura A, Yamasaki J, Nagano O, Yasuda T, Yonemura A, Tong Y, Wang H, Akiyama T, Matsumura K, Uemura N, Itoyama R, Bu L, Fu L, Hu X, Wei F, Mima K, Imai K, Hayashi H, Yamashita YI, Miyamoto Y, Baba H, Ishimoto T.
Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer.
JCI Insight
2023
PubMed ID: 37733442
DOI: 10.1172/jci.insight.163022
|
|
21462
Baba K, Uemura K, Nakazato R, Ijaz F, Takahashi S, Ikegami K.
Δ3-tubulin impairs mitotic spindle morphology and increases nuclear size in pancreatic cancer cells.
Med Mol Morphol
2023
PubMed ID: 37930423
DOI: 10.1007/s00795-023-00373-w
|
|
21531
Imanishi M, Inoue T, Fukushima K, Yamashita R, Nakayama R, Nojima M, Kondo K, Gomi Y, Tsunematsu H, Goto K, Miyamoto L, Funamoto M, Denda M, Ishizawa K, Otaka A, Fujino H, Ikeda Y, Tsuchiya K.
CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.
J Pharmacol Sci
2023
153(4):232-242
PubMed ID: 37973221
DOI: 10.1016/j.jphs.2023.10.003
|
|
21954
Kariya Y, Gu J, Kariya Y.
Integrin α6β4 Confers Doxorubicin Resistance in Cancer Cells by Suppressing Caspase-3-Mediated Apoptosis: Involvement of N-Glycans on β4 Integrin Subunit
Biomolecules
2023
13(12):1752
PubMed ID: 38136623
DOI: 10.3390/biom13121752
|
|
17509
Maneenet J, Tawila AM, Omar AM, Phan ND, Ojima C, Kuroda M, Sato M, Mizoguchi M, Takahashi I, Awale S.
Chemical Constituents of Callistemon subulatus and Their Anti-Pancreatic Cancer Activity against Human PANC-1 Cell Line
Plants (Basel)
2022
11(19):2466
PubMed ID: 36235333
DOI: 10.3390/plants11192466
|
|
17698
Yuji Doi, Daigo Wakana, Satoshi Kitaoka, Hisashi Takeda, Eiji Tanaka, Tomoo Hosoe
Secalonic Acid and Benzoic Acid Analogues Exhibiting Cyto toxicity against Cancer Cells Isolated from <i>Claviceps yanagawaensis</i>
Advances in Microbiology
2022
12:649-670
DOI: 10.4236/aim.2022.1212045
|
|
17709
Kimura A, Arai T, Ueno M, Oyama K, Yu H, Yamashita S, Otome Y, Taguchi M.
Synthesis of Small Peptide Nanogels Using Radiation Crosslinking as a Platform for Nano-Imaging Agents for Pancreatic Cancer Diagnosis
Pharmaceutics
2022
14(11):2400
PubMed ID: 36365217
DOI: 10.3390/pharmaceutics14112400
|
|
20214
Ando H, Murakami Y, Eshima K, Ishida T.
A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML).
Cancer Rep (Hoboken)
2022
e1485
PubMed ID: 34173723
DOI: 10.1002/cnr2.1485
|
|
20471
Guan W, Nakata K, Sagara A, Iwamoto C, Endo S, Matsuda R, Matsumoto S, Ikenaga N, Shindo K, Moriyama T, Onishi H, Ohuchida K, Oda Y, Nakamura M.
ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway.
Pancreatology
2022
PubMed ID: 34642112
DOI: 10.1016/j.pan.2021.09.012
|
|
20558
Kohyama A, Kim MJ, Yokoyama R, Sun S, Omar AM, Phan ND, Meselhy MR, Tsuge K, Awale S, Matsuya Y.
Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
Bioorg Med Chem
2022
54:116563
PubMed ID: 34942553
DOI: 10.1016/j.bmc.2021.116563
|
|
16170
Yoshioka H, Kawamura T, Muroi M, Kondoh Y, Honda K, Kawatani M, Aono H, Waldmann H, Watanabe N, Osada H.
Identification of a Small Molecule That Enhances Ferroptosis via Inhibition of Ferroptosis Suppressor Protein 1 (FSP1)
ACS Chem Biol
2022
Feb 7.
PubMed ID: 35128925
DOI: 10.1021/acschembio.2c00028
|
|
20570
Vaes RDW, van Dijk DPJ, Farshadi EA, Olde Damink SWM, Rensen SS, Langen RC.
Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
J Cachexia Sarcopenia Muscle
2022
PubMed ID: 35146962
DOI: 10.1002/jcsm.12917
|
|
20531
Fujita T, Lin J, Kimishima A, Arai M, Takikawa H, Ogura Y.
Synthesis and Biological Evaluation of Cajaninstilbene Acid and Amorfrutins A-D as Cytotoxic Agents against Human Pancreatic Carcinoma PANC-1 Cells.
Biosci Biotechnol Biochem
2022
PubMed ID: 35157035
DOI: 10.1093/bbb/zbac025
|
|
20592
Shinkawa T, Ohuchida K, Mochida Y, Sakihama K, Iwamoto C, Abe T, Ideno N, Mizuuchi Y, Shindo K, Ikenaga N, Moriyama T, Nakata K, Oda Y, Nakamura M.
Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
J Exp Clin Cancer Res
2022
41(1):89
PubMed ID: 35272688
DOI: 10.1186/s13046-022-02301-9
|
|
20717
Yamakawa K, Koyanagi-Aoi M, Uehara K, Masuda A, Yanagimoto H, Toyama H, Fukumoto T, Kodama Y, Aoi T.
Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
PLoS One
2022
17(5)
PubMed ID: 35617311
DOI: 10.1371/journal.pone.0266620
|
|
16760
Yuki A, Fujii C, Yamanoi K, Matoba H, Harumiya S, Kawakubo M, Nakayama J.
Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy
Cancer Sci
2022
113(2):576-586
PubMed ID: 34808019
DOI: 10.1111/cas.15209
|
|
20774
Kubota Y, Fujioka Y, Patil A, Takagi Y, Matsubara D, Iijima M, Momose I, Naka R, Nakai K, Noda NN, Takekawa M.
Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.
Nat Commun
2022
13(1):4063
PubMed ID: 35831322
DOI: 10.1038/s41467-022-31690-w
|
|
16849
Nguyen Ngoc Thanh Luan, Takuya Okada, Ruka Arata, Lanke Prudhvi, Moe Miyaguchi, Yuri Kodama, Suresh Awale, Naoki Toyooka
Structure-activity relationship study of 4′-O-methylgrynullarin derivatives for the development of novel anticancer agents based on anti-austerity strategy
Tetrahedron
2022
132931
DOI: 10.1016/j.tet.2022.132931
|
|
20799
Fujimoto M, Takii R, Matsumoto M, Okada M, Nakayama KI, Nakato R, Fujiki K, Shirahige K, Nakai A.
HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.
Nat Commun
2022
13(1):4355
PubMed ID: 35906200
DOI: 10.1038/s41467-022-32034-4
|
|
20858
Miyazaki N, Shiratori R, Oshima T, Zhang Z, Valencia R, Kranrod J, Fang L, Seubert JM, Ito K, Aoki S.
PINK1-dependent and Parkin-independent mitophagy is involved in reprogramming of glycometabolism in pancreatic cancer cells.
Biochem Biophys Res Commun
2022
625:167-173
PubMed ID: 35963163
DOI: 10.1016/j.bbrc.2022.08.004
|
|
20976
Liu Z, Hayashi H, Matsumura K, Ogata Y, Sato H, Shiraishi Y, Uemura N, Miyata T, Higashi T, Nakagawa S, Mima K, Imai K, Baba H.
Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Br J Cancer
2022
PubMed ID: 36536047
DOI: 10.1038/s41416-022-02106-9
|
|
18117
Chao D, Ariake K, Sato S, Ohtsuka H, Takadate T, Ishida M, Masuda K, Maeda S, Miura T, Mitachi K, Yu XJ, Fujishima F, Mizuma M, Nakagawa K, Morikawa T, Kamei T, Unno M.
Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer
Oncol Rep
2021
45(6):90
PubMed ID: 33846782
DOI: 10.3892/or.2021.8041
|
|
13280
Labib PL, Yaghini E, Davidson BR, MacRobert AJ, Pereira SP.
5-Aminolevulinic acid for fluorescence-guided surgery in pancreatic cancer: Cellular transport and fluorescence quantification studies.
Transl Oncol
2021
PubMed ID: 33059124
DOI: 10.1016/j.tranon.2020.100886
|
|
13355
Yoshiya S, Itoh S, Yoshizumi T, Yugawa K, Kurihara T, Toshima T, Harada N, Hashisako M, Yonemasu H, Fukuzawa K, Oda Y, Mori M.
Impact of Capicua on Pancreatic Cancer Progression.
Ann Surg Oncol
2021
28(6):3198-3207
PubMed ID: 33216264
DOI: 10.1245/s10434-020-09339-z
|
|
20018
Odagiri T, Asano Y, Kagiya T, Matsusaki M, Akashi M, Shimoda H, Hakamada K.
The Cell Line-Dependent Diversity in Initial Morphological Dynamics of Pancreatic Cancer Cell Peritoneal Metastasis Visualized by an Artificial Human Peritoneal Model.
J Surg Res
2021
261:351-360
PubMed ID: 33493887
DOI: 10.1016/j.jss.2020.12.046
|
|
20025
Sun S, Kim MJ, Dibwe DF, Omar AM, Athikomkulchai S, Phrutivorapongkul A, Okada T, Tsuge K, Toyooka N, Awale S.
Anti-Austerity Activity of Thai Medicinal Plants: Chemical Constituents and Anti-Pancreatic Cancer Activities of Kaempferia parviflora.
Plants (Basel)
2021
10(2)
PubMed ID: 33503922
DOI: 10.3390/plants10020229
|
|
20035
Ito N, Yamada M, Morishita K, Nojima S, Motooka K, Sakata N, Asuka T, Otsu R, Takamatsu S, Kamada Y, Mori S, Akita H, Eguchi H, Morii E, Miyoshi E.
Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism.
Glycoconj J
2021
38(1):45-54
PubMed ID: 33523362
DOI: 10.1007/s10719-020-09970-8
|
|
20094
Sun S, Omar AM, Kim MJ, Phan ND, Chulikhit Y, Awale S.
Chemical constituents of Thai Piper ribesoides and their antiausterity activities against the PANC-1 human pancreatic cancer cell line.
Fitoterapia
2021
104901
PubMed ID: 33794305
DOI: 10.1016/j.fitote.2021.104901
|
|
20096
Kurogi S, Hijiya N, Hidano S, Sato S, Uchida T, Tsukamoto Y, Nakada C, Yada K, Hirashita T, Inomata M, Murakami K, Takahashi N, Kobayashi T, Moriyama M.
Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential.
Pathobiology
2021
1-9
PubMed ID: 33794543
DOI: 10.1159/000514593
|
|
20099
Furuhashi S, Morita Y, Ida S, Muraki R, Kitajima R, Takeda M, Kikuchi H, Hiramatsu Y, Setou M, Takeuchi H.
Ephrin Receptor A4 Expression Enhances Migration, Invasion and Neurotropism in Pancreatic Ductal Adenocarcinoma Cells.
Anticancer Res
2021
41(4):1733-1744
PubMed ID: 33813377
DOI: 10.21873/anticanres.14938
|
|
20164
Sagara A, Nakata K, Yamashita T, Guan W, Zhong P, Matsumoto S, Endo S, Iwamoto C, Shindo K, Ikenaga N, Moriyama T, Ohuchida K, Mizumoto K, Nakamura M.
New high-throughput screening detects compounds that suppress pancreatic stellate cell activation and attenuate pancreatic cancer growth.
Pancreatology
2021
PubMed ID: 33965328
DOI: 10.1016/j.pan.2021.04.002
|
|
20167
Nakamura K, Sho M, Akahori T, Nishiwada S, Kunishige T, Nakagawa K, Nagai M, Takagi T, Terai T, Ikeda N.
Clinical relevance of CD70 expression in resected pancreatic cancer: Prognostic value and therapeutic potential.
Pancreatology
2021
21(3):573-580
PubMed ID: 33541781
DOI: 10.1016/j.pan.2021.01.013
|
|
20186
Saito R, Kawaida H, Hosomura N, Amemiya H, Itakura J, Yamamoto A, Takiguchi K, Maruyama S, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Sudo M, Inoue S, Kono H, Ichikawa D.
Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer Progression.
Ann Surg Oncol
2021
PubMed ID: 34101067
DOI: 10.1245/s10434-021-10250-4
|
|
20189
Suzuki M, Anko M, Ohara M, Matsumoto KI, Hasegawa S.
Radiation-Induced Autophagy in Human Pancreatic Cancer Cells is Critically Dependent on G2 Checkpoint Activation: A Mechanism of Radioresistance in Pancreatic Cancer.
Int J Radiat Oncol Biol Phys
2021
PubMed ID: 34112559
DOI: 10.1016/j.ijrobp.2021.04.001
|
|
14512
Ando H, Eshima K, Ishida T.
Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model
Biol Pharm Bull
2021
4(2):266-270
PubMed ID: 33518679
DOI: 10.1248/bpb.b20-00825
|
|
20254
Sun S, Kim MJ, Omar AM, Duy Phan N, Aoike M, Awale S.
GDP Induces PANC-1 Human Pancreatic Cancer Cell Death Preferentially under Nutrient Starvation by Inhibiting PI3K/Akt/mTOR/Autophagy Signaling Pathway.
Chem Biodivers
2021
PubMed ID: 34213070
DOI: 10.1002/cbdv.202100389
|
|
15289
Yahagi H, Yahagi T, Matsumura M, Igarashi K, Yokoyama N, Matsuzaki K.
Inhibitory activity of flavonoids from Ephedrae Herba on hypoxia signaling in PANC-1 cells and the evaluation of their mechanisms
J Nat Med
2021
75(3):612-622
PubMed ID: 33813664
DOI: 10.1007/s11418-021-01507-z
|
|
20367
Kariya Y, Oyama M, Kariya Y, Hashimoto Y.
Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility.
Biomolecules
2021
11(9)
PubMed ID: 34572536
DOI: 10.3390/biom11091323
|
|
20431
Shiozaki A, Konishi T, Kosuga T, Kudou M, Kurashima K, Inoue H, Shoda K, Arita T, Konishi H, Morimura R, Komatsu S, Ikoma H, Toma A, Kubota T, Fujiwara H, Okamoto K, Otsuji E.
Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells.
Int J Oncol
2021
59(4)
PubMed ID: 34414448
DOI: 10.3892/ijo.2021.5256
|
|
20436
Daikuzono H, Yamazaki M, Sato Y, Takahashi T, Yamagata K.
Development of a DELFIA method to detect oncofetal antigen ROR1-positive exosomes.
Biochem Biophys Res Commun
2021
578:170-176
PubMed ID: 34597914
DOI: 10.1016/j.bbrc.2021.08.054
|
|
20448
Shimasaki T, Yamamoto S, Omura R, Ito K, Nishide Y, Yamada H, Ohtomo K, Ishisaka T, Okano K, Ogawa T, Tsuji H, Matsuo Y, Minamoto T, Tomosugi N, Ferain E, Ochiya T.
Novel Platform for Regulation of Extracellular Vesicles and Metabolites Secretion from Cells Using a Multi-Linkable Horizontal Co-Culture Plate.
Micromachines (Basel)
2021
12(11)
PubMed ID: 34832842
DOI: 10.3390/mi12111431
|
|
16171
Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A.
Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion
Elife
2021
10:e66721
PubMed ID: 34590580
DOI: 10.7554/eLife.66721
|
|
16214
PRAMOD NEPAL, YUTO HOZAKA, TAKAKO TANAKA, MASUMI WADA, SHUNICHI ASAI, CHIKASHI MINEMURA, TETSUYA IDICHI, TAKAAKI ARIGAMI, HIROSHI KURAHARA, NAOHIKO SEKI, TAKAO OHTSUKA
Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma
Anticancer Res
2021
41(10):4821-4836
PubMed ID: 34593431
DOI: 10.21873/anticanres.15297
|
|
16522
Kawatani M, Aono H, Hiranuma S, Shimizu T, Muroi M, Ogawa N, Ohishi T, Ohba SI, Kawada M, Nogawa T, Okano A, Hashizume D, Osada H.
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth
ACS Chem Biol
2021
16(8):1576-1586
PubMed ID: 34296611
DOI: 10.1021/acschembio.1c00480
|
|
16701
Chinen T, Yamazaki K, Hashimoto K, Fujii K, Watanabe K, Takeda Y, Yamamoto S, Nozaki Y, Tsuchiya Y, Takao D, Kitagawa D.
Centriole and PCM cooperatively recruit CEP192 to spindle poles to promote bipolar spindle assembly
J Cell Biol
2021
220(2):e202006085
PubMed ID: 33443571
DOI: 10.1083/jcb.202006085
|
|
16776
Sijia Sun, Min Jo Kim, Ashraf M. Omar, Nguyen Duy Phan, Suresh Awale
(+)-Panduratin A induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K/Akt/mTOR/autophagy signaling pathway
Phytomedicine Plus
2021
1:100101
DOI: 10.1016/j.phyplu.2021.100101
|
|
16777
Liang C, Fukuda T, Isaji T, Duan C, Song W, Wang Y, Gu J.
α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma
Biochim Biophys Acta Gen Subj
2021
1865(6):12987
PubMed ID: 33571582
DOI: 10.1016/j.bbagen.2021.129870
|
|
16778
Jinno N, Yoshida M, Hayashi K, Naitoh I, Hori Y, Natsume M, Kato A, Kachi K, Asano G, Atsuta N, Sahashi H, Kataoka H.
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
Cancer Sci
2021
112(2):668-678
PubMed ID: 33053268
DOI: 10.1111/cas.14689
|
|
16779
Mang D, Roy SR, Zhang Q, Hu X, Zhang Y.
Heparan Sulfate-Instructed Self-Assembly Selectively Inhibits Cancer Cell Migration
ACS Appl Mater Interfaces
2021
13(15):17236-17242
PubMed ID: 33830729
DOI: 10.1021/acsami.1c00934
|
|
19227
Hirai K, Watanabe S, Nishijima N, Shibata K, Hase A, Yamanaka T, Inazu M.
Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
Int J Mol Sci
2020
21(15):5190
PubMed ID: 32707889
DOI: 10.3390/ijms21155190
|
|
19263
Furuhashi S, Sakaguchi T, Murakami T, Fukushima M, Morita Y, Ikegami K, Kikuchi H, Setou M, Takeuchi H.
Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma
Pancreas
2020
49(3):442-454
PubMed ID: 32132519
DOI: 10.1097/MPA.0000000000001506
|
|
19318
Atsumi S, Katoh H, Komura D, Hashimoto I, Furuya G, Koda H, Konishi H, Suzuki R, Yamamoto A, Yuba S, Abe H, Rino Y, Oshima T, Ushiku T, Fukayama M, Seto Y, Ishikawa S.
Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases
Commun Biol
2020
3(1):58
PubMed ID: 33067514
DOI: 10.1038/s42003-020-01305-5
|
|
11767
Tang R, Kimishima A, Ishida R, Setiawan A, Arai M.
Selective cytotoxicity of epidithiodiketopiperazine DC1149B, produced by marine-derived Trichoderma lixii on the cancer cells adapted to glucose starvation.
J Nat Med
2020
74(1):153-158
PubMed ID: 31435860
DOI: 10.1007/s11418-019-01357-w
|
|
11836
Tachikawa M, Kaneko Y, Ohtsuki S, Uchida Y, Watanabe M, Ohtsuka H, Terasaki T.
Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines.
J Pharm Sci
2020
109(2):1161-1168
PubMed ID: 31605689
DOI: 10.1016/j.xphs.2019.09.024
|
|
6956
Sato M, Matsumoto M, Saiki Y, Alam M, Nishizawa H, Rokugo M, Brydun A, Yamada S, Kaneko MK, Funayama R, Ito M, Kato Y, Nakayama K, Unno M, Igarashi K.
BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition.
Cancer Res
2020
80(6):1279-1292
PubMed ID: 31919242
DOI: 10.1158/0008-5472.CAN-18-4099
|
|
9820
Mai T T Nguyen, Khang D H Nguyen, Phu H Dang, Hai X Nguyen, Suresh Awale 1, Nhan T Nguyen
Calosides A-F, Cardenolides From Calotropis gigantea and Their Cytotoxic Activity
J Nat Prod
2020
83(2):385-391
PubMed ID: 31967821
DOI: 10.1021/acs.jnatprod.9b00875
|
|
11920
Takumi Chinen , Shohei Yamamoto, Yutaka Takeda , Koki Watanabe, Kanako Kuroki , Kaho Hashimoto , Daisuke Takao , Daiju Kitagawa
NuMA assemblies organize microtubule asters to establish spindle bipolarity in acentrosomal human cells
EMBO J
2020
PubMed ID: 31782546
DOI: 10.15252/embj.2019102378
|
|
11941
Alexander BE, Sun S, Palframan MJ, Kociok-Köhn G, Dibwe DF, Watanabe S, Caggiano L, Awale S, Lewis SE.
Sidechain Diversification of Grandifloracin Allows Identification of Analogues with Enhanced Anti-Austerity Activity against Human PANC-1 Pancreatic Cancer Cells.
ChemMedChem
2020
PubMed ID: 31821731
DOI: 10.1002/cmdc.201900549
|
|
12029
Tang R, Kimishima A, Setiawan A, Arai M.
Secalonic acid D as a selective cytotoxic substance on the cancer cells adapted to nutrient starvation.
J Nat Med
2020
PubMed ID: 32002808
DOI: 10.1007/s11418-020-01390-0
|
|
12030
Yoshizawa N, Sugimoto K, Tameda M, Inagaki Y, Ikejiri M, Inoue H, Usui M, Ito M, Takei Y.
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Oncol Lett
2020
PubMed ID: 32218818
DOI: 10.3892/ol.2020.11357
|
|
12081
Noda S, Chikazawa K, Suzuki Y, Imaizumi Y, Yamamura H.
Involvement of the γ1 subunit of the large-conductance Ca2+-activated K+ channel in the proliferation of human somatostatinoma cells.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 32178873
DOI: 10.1016/j.bbrc.2020.02.176
|
|
12159
Ahmed M. Zaher, Jianyu Lin, Masayoshi Arai
Cytotoxic Activity of Abietane-Type Diterpenes Isolated From Taxodium distichum Against Cancer Cells Adapted to Nutrient-Starved Conditions
SAGE Journals
2020
DOI: 10.1177/1934578X20915298
|
|
12994
Yoshida J, Ishikawa T, Endo Y, Matsumura S, Ota T, Mizushima K, Hirai Y, Oka K, Okayama T, Sakamoto N, Inoue K, Kamada K, Uchiyama K, Takagi T, Naito Y, Itoh Y.
Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Oncol Rep
2020
PubMed ID: 32627027
DOI: 10.3892/or.2020.7595
|
|
13007
Takenaga K, Akimoto M, Koshikawa N, Nagase H.
Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
PLoS One
2020
PubMed ID: 32340025
DOI: 10.1371/journal.pone.0232230
|
|
13085
Tang R, Zhou D, Kimishima A, Setiawan A, Arai M.
Selective cytotoxicity of marine-derived fungal metabolite (3S,6S)-3,6-dibenzylpiperazine-2,5-dione against cancer cells adapted to nutrient starvation.
J Antibiot (Tokyo)
2020
PubMed ID: 32587348
DOI: 10.1038/s41429-020-0340-3
|
|
13088
Hirashita T, Hirashita Y, Iwashita Y, Endo Y, Kiyonaga M, Matsumoto S, Hijiya N, Moriyama M, Murakami K, Inomata M.
S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas.
Ann Gastroenterol Surg
2020
PubMed ID: 33005852
DOI: 10.1002/ags3.12367
|
|
13192
Tawila AM, Sun S, Kim MJ, Omar AM, Dibwe DF, Awale S.
A Triterpene Lactone from Callistemon citrinus Inhibits the PANC-1 Human Pancreatic Cancer Cells Viability through Suppression of Unfolded Protein Response.
Chem Biodivers
2020
PubMed ID: 32865330
DOI: 10.1002/cbdv.202000495
|
|
13225
Zheng B, Qu J, Ohuchida K, Feng H, Chong SJF, Yan Z, Piao Y, Liu P, Sheng N, Eguchi D, Ohtsuka T, Mizumoto K, Liu Z, Pervaiz S, Gong P, Nakamura M.
LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer.
Theranostics
2020
PubMed ID: 32929348
DOI: 10.7150/thno.47001
|
|
13239
Tanaka T, Okada R, Hozaka Y, Wada M, Moriya S, Satake S, Idichi T, Kurahara H, Ohtsuka T, Seki N.
Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes.
Cancers (Basel)
2020
PubMed ID: 32977589
DOI: 10.3390/cancers12102731
|
|
13308
Miyata S, Nakamura T, Kitanaka S.
3EZ, 20Ac-ingenol-induced Apoptosis in Chemoresistant Cancers With Cyclin D1 Accumulation.
Anticancer Res
2020
PubMed ID: 33109561
DOI: 10.21873/anticanres.14644
|
|
13335
Abdel-Naime WA, Kimishima A, Setiawan A, Fahim JR, Fouad MA, Kamel MS, Arai M.
Mitochondrial Targeting in an Anti-Austerity Approach Involving Bioactive Metabolites Isolated from the Marine-Derived Fungus Aspergillus sp.
Mar Drugs
2020
PubMed ID: 33171814
DOI: 10.3390/md18110555
|
|
13450
Haimin Feng, Taiki Moriyama, Kenoki Ohuchida, Nan Sheng, Chika Iwamoto, Koji Shindo, Kengo Shirahane, Naoki Ikenaga, Shuntaro Nagai, Kohei Nakata, Kazuhiro Mizumoto, Masafumi Nakamura
N-acetyl Cysteine Induces Quiescent-like Pancreatic Stellate Cells From an Active State and Attenuates Cancer-stroma Interactions
Journal of Experimental & Clinical Cancer Research
2020
DOI: 10.21203/rs.3.rs-89408/v1
|
|
13611
Ando Y, Ohuchida K, Otsubo Y, Kibe S, Takesue S, Abe T, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Oda Y, Nakamura M.
Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
PLoS One
2020
15(1):e0228015
PubMed ID: 31999765
DOI: 10.1371/journal.pone.0228015
|
|
13621
Yahagi H, Yahagi T, Furukawa M, Matsuzaki K.
Antiproliferative and Antimigration Activities of Beauvericin Isolated from Isaria sp. on Pancreatic Cancer Cells
Molecules
2020
25(19):4586
PubMed ID: 33050002
DOI: 10.3390/molecules25194586
|
|
13837
Machihara K, Namba T.
Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma
Biochem Biophys Res Commun
2020
527(1):289-296
PubMed ID: 32446382
DOI: 10.1016/j.bbrc.2020.04.109
|
|
14801
Takeda Y, Yamazaki K, Hashimoto K, Watanabe K, Chinen T, Kitagawa D.
The centriole protein CEP76 negatively regulates PLK1 activity in the cytoplasm for proper mitotic progression
J Cell Sci
2020
133(19):jcs241281
PubMed ID: 32878946
DOI: 10.1242/jcs.241281
|
|
14832
Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.
Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines
Arch Virol
2020
165(1):207-214
PubMed ID: 31776677
DOI: 10.1007/s00705-019-04474-9
|
|
22121
Matsuda A, Kuno A, Yoshida M, Wagatsuma T, Sato T, Miyagishi M, Zhao J, Suematsu M, Kabe Y, Narimatsu H.
Comparative Glycomic Analysis of Exosome Subpopulations Derived from Pancreatic Cancer Cell Lines
J Proteome Res
2020
19(6):2516-2524
PubMed ID: 32338917
DOI: 10.1021/acs.jproteome.0c00200
|
|
22122
Usami M, Kikuchi S, Takada K, Ono M, Sugama Y, Arihara Y, Hayasaka N, Nakamura H, Ikeda Y, Hirakawa M, Yoshida M, Miyanishi K, Kobune M, Kato J.
FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells
Pancreas
2020
49(1):135-142
PubMed ID: 31856089
DOI: 10.1097/MPA.0000000000001462
|
|
11190
Okumura T, Ohuchida K, Kibe S, Iwamoto C, Ando Y, Takesue S, Nakayama H, Abe T, Endo S, Koikawa K, Sada M, Horioka K, Mochidome N, Arita M, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M.
Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix.
Int. J. Cancer
2019
144(6):1401-1413
PubMed ID: 30152542
DOI: 10.1002/ijc.31775
|
|
11218
Arima K, Ohmuraya M, Miyake K, Koiwa M, Uchihara T, Izumi D, Gao F, Yonemura A, Bu L, Okabe H, Imai K, Hashimoto D, Baba Y, Chikamoto A, Yamashita YI, Furukawa T, Araki K, Baba H, Ishimoto T.
Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
Oncogene
2019
38(8):1211-1224
PubMed ID: 30250298
DOI: 10.1038/s41388-018-0510-y
|
|
11436
Yan Z, Ohuchida K, Zheng B, Okumura T, Takesue S, Nakayama H, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M.
CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
J. Cancer Res. Clin. Oncol.
2019
PubMed ID: 30770989
DOI: 10.1007/s00432-019-02860-z
|
|
11483
Khalid M, Idichi T, Seki N, Wada M, Yamada Y, Fukuhisa H, Toda H, Kita Y, Kawasaki Y, Tanoue K, Kurahara H, Mataki Y, Maemura K, Natsugoe S.
Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 Regulation.
Cancers (Basel)
2019
PubMed ID: 30866526
DOI: 10.3390/cancers11030327
|
|
11480
Fukuhisa H, Seki N, Idichi T, Kurahara H, Yamada Y, Toda H, Kita Y, Kawasaki Y, Tanoue K, Mataki Y, Maemura K, Natsugoe S.
Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
J. Hum. Genet.
2019
PubMed ID: 30858505
DOI: 10.1038/s10038-019-0584-6
|
|
5027
Nishizawa N1, Harada H1, Kumamoto Y1, Kaizu T, Katoh H, Tajima H, Ushiku H, Yokoi K, Igarashi K, Fujiyama Y, Okuwaki K, Iwai T, Watanabe M, Yamashita K1
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Cancer Sci
2019
110(9):2846-2855
PubMed ID: 31325200
DOI: 10.1111/cas.14134
|
|
11571
Nakayama H, Ohuchida K, Yonenaga A, Sagara A, Ando Y, Kibe S, Takesue S, Abe T, Endo S, Koikawa K, Okumura T, Shido K, Miyoshi K, Nakata K, Moriyama T, Miyasaka Y, Inoue S, Ohtsuka T, Mizumoto K, Nakamura M.
S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.
Int. J. Oncol.
2019
PubMed ID: 31180531
DOI: 10.3892/ijo.2019.4812
|
|
11575
Yan Z, Ohuchida K, Fei S, Zheng B, Guan W, Feng H, Kibe S, Ando Y, Koikawa K, Abe T, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Hashizume M, Nakamura M.
Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
J. Exp. Clin. Cancer Res.
2019
PubMed ID: 31133044
DOI: 10.1186/s13046-019-1226-8
|
|
11779
Zhao H, Jiang X, Duan L, Yang L, Wang W, Ren Z.
Liraglutide suppresses the metastasis of PANC-1 co-cultured with pancreatic stellate cells through modulating intracellular calcium content.
Endocr. J.
2019
PubMed ID: 31474673
DOI: 10.1507/endocrj.EJ19-0215
|
|
11811
Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP.
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.
Cancers (Basel)
2019
11(9):1372
PubMed ID: 31527446
DOI: 10.3390/cancers11091372
|
|
6913
Kumaramangalam Jeyalakshmi, et al
Highly active copper(I) complexes of aroylthiourea ligands against cancer cells – synthetic and biological studies
New J Chem
2019
43:3188
DOI: 10.1039/C8NJ04246B
|
|
9414
Yoshihito Osugi, Katsumi Fumoto 1, Akira Kikuchi 2
CKAP4 Regulates Cell Migration via the Interaction With and Recycling of Integrin
Mol Cell Biol
2019
39(16):e00073-19
PubMed ID: 31160493
DOI: 10.1128/MCB.00073-19
|
|
11906
Kawase A, Inoue Y, Hirosoko M, Sugihara Y, Shimada H, Iwaki M.
Decrease in Multidrug Resistance-associated Protein 2 Activities by Knockdown of Phosphatidylinositol 4-phosphate 5-kinase in Hepatocytes and Cancer Cells.
J Pharm Pharm Sci
2019
PubMed ID: 31804920
DOI: 10.18433/jpps30444
|
|
11940
Shiratori R, Furuichi K, Yamaguchi M, Miyazaki N, Aoki H, Chibana H, Ito K, Aoki S.
Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner.
Sci Rep
2019
PubMed ID: 31822748
DOI: 10.1038/s41598-019-55296-3
|
|
10563
Koikawa K, Ohuchida K, Takesue S, Ando Y, Kibe S, Nakayama H, Endo S, Abe T, Okumura T, Horioka K, Sada M, Iwamoto C, Moriyama T, Nakata K, Miyasaka Y, Ohuchida R, Manabe T, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.
Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180.
Cancer Lett.
2018
412:143-154
PubMed ID: 29061505
DOI: 10.1016/j.canlet.2017.10.010
|
|
11140
Akimoto M, Maruyama R, Kawabata Y, Tajima Y, Takenaga K.
Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Cell Death Dis
2018
9(8):804
PubMed ID: 30038429
DOI: 10.1038/s41419-018-0851-z
|
|
4453
Idichi T, Seki N, Kurahara H, Fukuhisa H, Toda H, Shimonosono M, Yamada Y, Arai T, Kita Y, Kijima Y, Mataki Y, Maemura K, Natsugoe S.
Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p.
Oncotarget
2018
9(48):28849-28865
PubMed ID: 29988949
DOI: 10.18632/oncotarget.25599
|
|
4216
Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M.
Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction.
Cell Commun. Signal
2018
PubMed ID: 30180849
DOI: 10.1186/s12964-018-0262-x
|
|
4314
Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Terada K, Itadani M, Okada N, Hassan NMM, Nagatsuka H, Ikeda T, Nohno T, Fujita S.
DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Oncol. Res.
2018
PubMed ID: 28470144
DOI: 10.3727/096504017X14926874596386
|
|
4382
Kavatsurwa SM, Lombe BK, Feineis D, Dibwe DF, Maharaj V, Awale S, Bringmann G.
Ancistroyafungines A-D, 5,8'- and 5,1'-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells.
Fitoterapia
2018
PubMed ID: 30059720
DOI: 10.1016/j.fitote.2018.07.017
|
|
4383
Akimoto T, Umemura M, Nagasako A, Ohtake M, Fujita T, Yokoyama U, Eguchi H, Yamamoto T, Ishikawa Y.
Alternating magnetic field enhances cytotoxicity of Compound C.
Cancer Sci.
2018
109(11):3483-3493
PubMed ID: 30155931
DOI: 10.1111/cas.13781
|
|
4481
Blaise Kimbadi Lombe, Doris Feineis, Virima Mudogo, Reto Brun, Suresh Awale and Gerhard Bringmann
Michellamines A6 and A7, and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese Ancistrocladus liana and their antiausterity activities against pancreatic cancer cells
RSC Adv
2018
8:5243
PubMed ID: 35542436
DOI: 10.1039/c8ra00363g
|
|
4494
Inoko K, Hiraoka K, Inagaki A, Takahashi M, Kushibiki T, Hontani K, Takano H, Sato S, Takeuchi S, Nakamura T, Tsuchikawa T, Shichinohe T, Gruber HE, Jolly DJ, Kasahara N, Hirano S.
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer.
Cancer Gene Ther.
2018
25(7-8):184-195
PubMed ID: 29735994
DOI: 10.1038/s41417-018-0020-7
|
|
5802
Eguchi T et al
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.
PLoS One
2018
13(2):e0191109.
PubMed ID: 29415026
DOI: 10.1371/journal.pone.0191109
|
|
15051
Sun S, Phrutivorapongkul A, Dibwe DF, Balachandran C, Awale S.
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line
J Nat Prod
2018
81(8):1877-1883
PubMed ID: 30070833
DOI: 10.1021/acs.jnatprod.8b00405
|
|
15052
Fayez S, Feineis D, Aké Assi L, Kaiser M, Brun R, Awale S, Bringmann G.
Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells
Fitoterapia
2018
131:245-259
PubMed ID: 30419265
DOI: 10.1016/j.fitote.2018.11.006
|
|
9761
Arai M, Shin D, Kamiya K, Ishida R, Setiawan A, Kotoku N, Kobayashi M.
Marine spongean polybrominated diphenyl ethers, selective growth inhibitors against the cancer cells adapted to glucose starvation, inhibits mitochondrial complex II.
J Nat Med
2017
71:44-49
PubMed ID: 27449332
DOI: 10.1007/s11418-016-1025-x
|
|
9958
Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, Won Y, Yamashita M, Hidaka S, Yamashita S, Yamada S, Murata M, Tsukamoto S, Tachibana H.
FOXO3 is essential for CD44 expression in pancreatic cancer cells.
Oncogene
2017
36:2643-2654
PubMed ID: 27893718
DOI: 10.1038/onc.2016.426
|
|
10046
Abe T, Ohuchida K, Koikawa K, Endo S, Okumura T, Sada M, Horioka K, Zheng B, Moriyama T, Nakata K, Miyasaka Y, Manabe T, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.
Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination.
Int. J. Oncol.
2017
50:457-467
PubMed ID: 28035373
DOI: 10.3892/ijo.2016.3829
|
|
10053
Sivakumar B, Aswathy RG, Romero-Aburto R, Mitcham T, Mitchel KA, Nagaoka Y, Bouchard RR, Ajayan PM, Maekawa T, Sakthikumar DN.
Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents.
Biomater Sci
2017
5:432-443
PubMed ID: 28059418
DOI: 10.1039/c6bm00621c
|
|
10086
Nguyen NT, Nguyen MT, Nguyen HX, Dang PH, Dibwe DF, Esumi H, Awale S.
Constituents of the Rhizomes of Boesenbergia pandurata and Their Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Line.
J. Nat. Prod.
2017
80:141-148
PubMed ID: 28099006
DOI: 10.1021/acs.jnatprod.6b00784
|
|
10112
Asano M, Sakaguchi M, Tanaka S, Kashimura K, Mitani T, Kawase M, Matsumura H, Yamaguchi T, Fujita Y, Tabuse K.
Effects of Normothermic Conditioned Microwave Irradiation on Cultured Cells Using an Irradiation System with Semiconductor Oscillator and Thermo-regulatory Applicator.
Sci Rep
2017
7:41244
PubMed ID: 28145466
DOI: 10.1038/srep41244
|
|
10311
Kumazoe M, Takai M, Hiroi S, Takeuchi C, Kadomatsu M, Nojiri T, Onda H, Bae J, Huang Y, Takamatsu K, Yamashita S, Kangawa K, Tachibana H.
The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.
J. Biol. Chem.
2017
292:10813-10823
PubMed ID: 28507102
DOI: 10.1074/jbc.M116.772111
|
|
10337
Iwata T, Uchino T, Koyama A, Johmura Y, Koyama K, Saito T, Ishiguro S, Arikawa T, Komatsu S, Miyachi M, Sano T, Nakanishi M, Shimada M.
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
PLoS ONE
2017
12:e0178221
PubMed ID: 28558031
DOI: 10.1371/journal.pone.0178221
|
|
10399
Fujita M, Hasegawa A, Yamamori M, Okamura N.
In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
J. Exp. Clin. Cancer Res.
2017
36:91
PubMed ID: 28673319
DOI: 10.1186/s13046-017-0557-6
|
|
10448
Arai MA, Utsumi T, Yanase N, Fujimatsu T, Ishibashi M.
Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.
Chem. Pharm. Bull.
2017
65:784-795
PubMed ID: 28768932
DOI: 10.1248/cpb.c17-00305
|
|
10481
Endo S, Nakata K, Sagara A, Koikawa K, Ando Y, Kibe S, Takesue S, Nakayama H, Abe T, Okumura T, Moriyama T, Miyasaka Y, Ohuchida K, Ohtsuka T, Mizumoto K, Nakamura M.
Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells.
Pancreatology
2017
17:990-996
PubMed ID: 28927939
DOI: 10.1016/j.pan.2017.08.009
|
|
10537
Kawamura D, Takemoto Y, Nishimoto A, Ueno K, Hosoyama T, Shirasawa B, Tanaka T, Kugimiya N, Harada E, Hamano K.
Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.
Oncol. Rep.
2017
38:3238-3244
PubMed ID: 29048622
DOI: 10.3892/or.2017.5974
|
|
11010
Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko with antiausterity activities against PANC-1 human pancreatic cancer cells
RSC Adv.
2017
7, 53740-53751
DOI: 10.1039/C7RA11200A
|
|
5446
Endo S1, Nakata K2, Ohuchida K3, Takesue S1, Nakayama H1, Abe T1, Koikawa K, Okumura T, Sada M, Horioka K, Zheng B, Mizuuchi Y, Iwamoto C5, Murata M, Moriyama T, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M
Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice.
Gastroenterology
2017
152(6):1492-1506
PubMed ID: 28126348
DOI: 10.1053/j.gastro.2017.01.010
|
|
9171
Haruhiko Fuwa, Mizuho Sato
A Synthetic Analogue of Neopeltolide, 8,9-Dehydroneopeltolide, Is a Potent Anti-Austerity Agent Against Starved Tumor Cells
Mar Drugs
2017
15 (10)
PubMed ID: 29053565
DOI: 10.3390/md15100320
|
|
14191
Li J, Seupel R, Bruhn T, Feineis D, Kaiser M, Brun R, Mudogo V, Awale S, Bringmann G.
Jozilebomines A and B, Naphthylisoquinoline Dimers from the Congolese Liana Ancistrocladus ileboensis, with Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Cell Line
J Nat Prod
2017
80(10):2807-2817
PubMed ID: 29043798
DOI: 10.1021/acs.jnatprod.7b00650
|
|
14206
Nguyen HX, Nguyen MTT, Nguyen NT, Awale S.
Chemical Constituents of Propolis from Vietnamese Trigona minor and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line
J Nat Prod
2017
80(8):2345-2352
PubMed ID: 28783356
DOI: 10.1021/acs.jnatprod.7b00375
|
|
14225
Kumazoe M, Takai M, Hiroi S, Takeuchi C, Yamanouchi M, Nojiri T, Onda H, Bae J, Huang Y, Takamatsu K, Yamashita S, Yamada S, Kangawa K, Takahashi T, Tanaka H, Tachibana H.
PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
Sci Rep
2017
7(1):1917.
PubMed ID: 28507327
DOI: 10.1038/s41598-017-02162-9
|
|
14244
Idichi T, Seki N, Kurahara H, Yonemori K, Osako Y, Arai T, Okato A, Kita Y, Arigami T, Mataki Y, Kijima Y, Maemura K, Natsugoe S.
Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma
Oncotarget
2017
8(32):53180-53193
PubMed ID: 28881803
DOI: 10.18632/oncotarget.18261
|
|
14251
Yonemori K, Seki N, Idichi T, Kurahara H, Osako Y, Koshizuka K, Arai T, Okato A, Kita Y, Arigami T, Mataki Y, Kijima Y, Maemura K, Natsugoe S.
The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster
Oncotarget
2017
8(41):70097-70115
PubMed ID: 29050264
DOI: 10.18632/oncotarget.19591
|
|
14252
Maki T, Ikeda H, Kuroda A, Kyogoku N, Yamamura Y, Tabata Y, Abiko T, Tsuchikawa T, Hida Y, Shichinohe T, Tanaka E, Kaga K, Hatanaka K, Matsuno Y, Imai N, Hirano S.
Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western blotting and mRNA quantification
Int J Oncol
2017
50(1):129-140.
PubMed ID: 27922671
DOI: 10.3892/ijo.2016.3786
|
|
14378
Yonemori K, Seki N, Kurahara H, Osako Y, Idichi T, Arai T, Koshizuka K, Kita Y, Maemura K, Natsugoe S.
ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma
Cancer Sci
2017
108(1):124-135
PubMed ID: 27862697
DOI: 10.1111/cas.13119
|
|
14616
Igarashi T, Araki K, Yokobori T, Altan B, Yamanaka T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Handa T, Hosouchi Y, Nishiyama M, Oyama T, Shirabe K, Kuwano H.
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression
Oncotarget
2017
8(7):12290-12300
PubMed ID: 28103577
DOI: 10.18632/oncotarget.14703
|
|
14655
Ohishi T, Yoshida H, Katori M, Migita T, Muramatsu Y, Miyake M, Ishikawa Y, Saiura A, Iemura SI, Natsume T, Seimiya H.
Tankyrase-Binding Protein TNKS1BP1 Regulates Actin Cytoskeleton Rearrangement and Cancer Cell Invasion
Cancer Res
2017
77(9):2328-2338
PubMed ID: 28202517
DOI: 10.1158/0008-5472.CAN-16-1846
|
|
14681
Inaguma S, Wang Z, Lasota J, Onda M, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Pastan I, Miettinen M.
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Oncotarget
2017
8(16):26744-26754
PubMed ID: 28460459
DOI: 10.18632/oncotarget.15814
|
|
14726
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E.
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
Sci Rep
2017
7(1):5708
PubMed ID: 28720759
DOI: 10.1038/s41598-017-06137-8
|
|
14948
Inoue K, Ohtsuka H, Tachikawa M, Motoi F, Shijo M, Douchi D, Kawasaki S, Kawaguchi K, Masuda K, Fukase K, Naitoh T, Katayose Y, Egawa S, Unno M, Terasaki T.
MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells
Pancreas
2017
46(4):557-566
PubMed ID: 28196027
DOI: 10.1097/MPA.0000000000000778
|
|
9568
Chijiiwa Y, Moriyama T, Ohuchida K, Nabae T, Ohtsuka T, Miyasaka Y, Fujita H, Maeyama R, Manabe T, Abe A, Mizuuchi Y, Oda Y, Mizumoto K, Nakamura M.
Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.
Int. J. Oncol.
2016
48:1688-700
PubMed ID: 26892887
DOI: 10.3892/ijo.2016.3389
|
|
9592
Hijiya N, Tsukamoto Y, Nakada C, Tung Nguyen L, Kai T, Matsuura K, Shibata K, Inomata M, Uchida T, Tokunaga A, Amada K, Shirao K, Yamada Y, Mori H, Takeuchi I, Seto M, Aoki M, Takekawa M, Moriyama M.
Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.
Cancer Res.
2016
76:2612-25
PubMed ID: 26941286
DOI: 10.1158/0008-5472.CAN-15-1846
|
|
9624
Itonaga M, Matsuzaki I, Warigaya K, Tamura T, Shimizu Y, Fujimoto M, Kojima F, Ichinose M, Murata S.
Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
PLoS ONE
2016
11:e0151654
PubMed ID: 26999437
DOI: 10.1371/journal.pone.0151654
|
|
9748
Arai M, Kamiya K, Shin D, Matsumoto H, Hisa T, Setiawan A, Kotoku N, Kobayashi M.
N-Methylniphatyne A, a New 3-Alkylpyridine Alkaloid as an Inhibitor of the Cancer Cells Adapted to Nutrient Starvation, from an Indonesian Marine Sponge of Xestospongia sp.
Chem. Pharm. Bull.
2016
64:766-71
PubMed ID: 27373630
DOI: 10.1248/cpb.c16-00118
|
|
9938
Komura D, Isagawa T, Kishi K, Suzuki R, Sato R, Tanaka M, Katoh H, Yamamoto S, Tatsuno K, Fukayama M, Aburatani H, Ishikawa S.
CASTIN: a system for comprehensive analysis of cancer-stromal interactome.
BMC Genomics
2016
17:899
PubMed ID: 27829362
DOI: 10.1186/s12864-016-3207-z
|
|
10031
Hasebe F, Matsuda K, Shiraishi T, Futamura Y, Nakano T, Tomita T, Ishigami K, Taka H, Mineki R, Fujimura T, Osada H, Kuzuyama T, Nishiyama M.
Amino-group carrier-protein-mediated secondary metabolite biosynthesis in Streptomyces.
Nat. Chem. Biol.
2016
12:967-972
PubMed ID: 28288097
DOI: 10.1038/nchembio.2181
|
|
12659
Mohammad GH, Olde Damink SW, Malago M, Dhar DK, Pereira SP.
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
PLoS One
2016
11(3):e0151635
PubMed ID: 26989901
DOI: 10.1371/journal.pone.0151635
|
|
12907
Sada M, Ohuchida K, Horioka K, Okumura T, Moriyama T, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Nakamura M.
Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility
Cancer Lett
2016
372(2):210-8
PubMed ID: 26805763
DOI: 10.1016/j.canlet.2016.01.016
|
|
14122
Nguyen HX, Do TN, Le TH, Nguyen MT, Nguyen NT, Esumi H, Awale S.
Chemical Constituents of Mangifera indica and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line
J Nat Prod
2016
79(8):2053-9
PubMed ID: 27466882
DOI: 10.1021/acs.jnatprod.6b00381
|
|
7168
Miyamae M, Komatsu S, Ichikawa D, Kawaguchi T, Hirajima S, Okajima W, Ohashi T, Imamura T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E.
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.
Br. J. Cancer
2015
113:1467-76
PubMed ID: 26505678
DOI: 10.1038/bjc.2015.366
|
|
7235
Tsukahara T, Haniu H, Matsuda Y.
The PTB-Associated Splicing Factor/Peroxisome Proliferator-Activated Receptor Gamma Axis Regulates Autophagosome Formation in Human Pancreatic Cancer Cells.
Biores Open Access
2015
4:319-25
PubMed ID: 26309807
DOI: 10.1089/biores.2015.0018
|
|
7318
Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M.
Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Cancer Lett.
2015
365:132-40
PubMed ID: 26047573
DOI: 10.1016/j.canlet.2015.05.023
|
|
7331
Sakai S, Inamoto K, Ashida T, Takamura R, Taya M.
Cancer stem cell marker-expressing cell-rich spheroid fabrication from PANC-1 cells using alginate microcapsules with spherical cavities templated by gelatin microparticles.
Biotechnol. Prog.
2015
31:1071-6
PubMed ID: 26013961
DOI: 10.1002/btpr.2111
|
|
7358
Akimoto M, Iizuka M, Kanematsu R, Yoshida M, Takenaga K.
Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death.
PLoS ONE
2015
10:e0126605
PubMed ID: 25961833
DOI: 10.1371/journal.pone.0126605
|
|
7400
Nishiwada S, Sho M, Yasuda S, Shimada K, Yamato I, Akahori T, Kinoshita S, Nagai M, Konishi N, Nakajima Y.
Clinical significance of CD155 expression in human pancreatic cancer.
Anticancer Res.
2015
35:2287-97
PubMed ID: 25862891
|
|
7560
Shimodaira S, Hirabayashi K, Koya T, Higuchi Y, Sano K
Standard WT1 Expression Using Immunohistochemistry.
J Mol Biomark Diagn
2015
7:266
DOI: 10.4172/2155-9929.1000266
|
|
5019
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
SU11274 suppresses proliferation and motility of pancreatic cancer cells.
Oncol Lett
2015
10(3):1468-1472
PubMed ID: 26622692
DOI: 10.3892/ol.2015.3452
|
|
5025
Sakamoto K, Imai K, Higashi T, Taki K, Nakagawa S, Okabe H, Nitta H, Hayashi H, Chikamoto A, Ishiko T, Beppu T, Baba H.
Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
Cancer Sci
2015
106(9):1153-62
PubMed ID: 26132727
DOI: 10.1111/cas.12732
|
|
15017
Mizuuchi Y, Aishima S, Ohuchida K, Shindo K, Fujino M, Hattori M, Miyazaki T, Mizumoto K, Tanaka M, Oda Y.
Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition
Lab Invest
2015
95(2):193-206
PubMed ID: 25418581
DOI: 10.1038/labinvest.2014.138
|
|
15159
Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Proc Natl Acad Sci U S A
2015
112(29):E3816-25
PubMed ID: 26124144
DOI: 10.1073/pnas.1510077112
|
|
15225
Uetaki M, Tabata S, Nakasuka F, Soga T, Tomita M.
Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress
Sci Rep
2015
5:13896
PubMed ID: 26350063
DOI: 10.1038/srep13896
|
|
19321
El-Ghlban S, Kasai T, Shigehiro T, Yin HX, Sekhar S, Ida M, Sanchez A, Mizutani A, Kudoh T, Murakami H, Seno M.
Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells
Biomed Res Int
2014
2014:152659
PubMed ID: 24511528
DOI: 10.1155/2014/152659
|
|
5018
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
Frizzled-2: A potential novel target for molecular pancreatic cancer therapy.
Oncol Lett
2014
7(1):74-78
PubMed ID: 24348824
DOI: 10.3892/ol.2013.1681
|
|
13762
Fukuda N, Tsuchikawa T, Fukunaga A, Kawase H, Homma N, Nakamura T, Shichinohe T, Hirano S.
Validation of histological diagnostic methods for detecting endothelin B receptor expression
Oncol Rep
2014
31(4):1561-6
PubMed ID: 24549269
DOI: 10.3892/or.2014.3031
|
|
16020
Nguyen MT, Nguyen NT, Nguyen KD, Dau HT, Nguyen HX, Dang PH, Le TM, Nguyen Phan TH, Tran AH, Nguyen BD, Ueda JY, Awale S.
Geranyl dihydrochalcones from Artocarpus altilis and their antiausteric activity
Planta Med
2014
80(2-3):193-200
PubMed ID: 24431013
DOI: 10.1055/s-0033-1360181
|
|
16038
Lale SV, R G A, Aravind A, Kumar DS, Koul V.
AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy
Biomacromolecules
2014
15(5):1737-5
PubMed ID: 24689987
DOI: 10.1021/bm5001263
|
|
16629
Sakai T, Mashima H, Yamada Y, Goto T, Sato W, Dohmen T, Kamada K, Yoshioka M, Uchinami H, Yamamoto Y, Ohnishi H.
The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer
Pancreas
2014
43(6):909-16
PubMed ID: 24632547
DOI: 10.1097/MPA.0000000000000116
|
|
17133
Liu Y, Sakai S, Kawa S, Taya M.
Identification of hydrogen peroxide-secreting cells by cytocompatible coating with a hydrogel membrane
Anal Chem
2014
86(23):11592-8
PubMed ID: 25359398
DOI: 10.1021/ac503342k
|
|
18239
Kimura C, Hayashi M, Mizuno Y, Oike M.
Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2
Biochim Biophys Acta
2013
1830(10):4470-81
PubMed ID: 23668958
DOI: 10.1016/j.bbagen.2013.05.009
|
|
18275
Hasegawa N, Abei M, Yokoyama KK, Fukuda K, Seo E, Kawashima R, Nakano Y, Yamada T, Nakade K, Hamada H, Obata Y, Hyodo I.
Cyclophosphamide enhances antitumor efficacy of oncolytic adenovirus expressing uracil phosphoribosyltransferase (UPRT) in immunocompetent Syrian hamsters
Int J Cancer
2013
133(6):1479-88
PubMed ID: 23444104
DOI: 10.1002/ijc.28132
|
|
5024
Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, Konishi H, Takeshita H, Nagata H, Arita T, Hirajima S, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.
Br J Cancer
2013
108(2):361-9
PubMed ID: 23329235
DOI: 10.1038/bjc.2012.546
|
|
3714
Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.
Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
World J Gastroenterol
2013
19(11):1718-27
PubMed ID: 23555160
DOI: 10.3748/wjg.v19.i11.1718
|
|
19021
Awale S, Ueda JY, Athikomkulchai S, Abdelhamed S, Yokoyama S, Saiki I, Miyatake R.
Antiausterity agents from Uvaria dac and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition
J Nat Prod
2012
75(6):1177-83
PubMed ID: 22676269
DOI: 10.1021/np300295h
|
|
19022
Awale S, Ueda JY, Athikomkulchai S, Dibwe DF, Abdelhamed S, Yokoyama S, Saiki I, Miyatake R.
Uvaridacols E-H, highly oxygenated antiausterity agents from Uvaria dac
J Nat Prod
2012
75(11):1999-2002
PubMed ID: 23092429
DOI: 10.1021/np300596c
|
|
19118
p38MAPK suppresses chronic pancreatitis by regulating HSP27 and BAD expression
p38MAPK suppresses chronic pancreatitis by regulating HSP27 and BAD expression
Free Radic Biol Med
2012
52(11-12):2284-91
PubMed ID: 22549003
DOI: 10.1016/j.freeradbiomed.2012.03.010
|
|
5020
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
nsulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.
J Cell Biochem
2012
113(8):2714-20
PubMed ID: 22441995
DOI: 10.1002/jcb.24149
|
|
5026
Waraya M, Yamashita K, Katoh H, Ooki A, Kawamata H, Nishimiya H, Nakamura K, Ema A, Watanabe M.
Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.
BMC Cancer
2012
12:397
PubMed ID: 22958219
DOI: 10.1186/1471-2407-12-397
|
|
5032
Igarashi S, Matsubara T, Harada K, Ikeda H, Sato Y, Sasaki M, Matsui O, Nakanuma Y.
Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Histopathology
2012
61(2):266-76
PubMed ID: 22594685
DOI: 10.1111/j.1365-2559.2012.04218.x
|
|
12868
Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.
Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach
PLoS One
2012
7(7):e39545
PubMed ID: 22808043
DOI: 10.1371/journal.pone.0039545
|
|
16079
Yamato I, Sho M, Shimada K, Hotta K, Ueda Y, Yasuda S, Shigi N, Konishi N, Tsujikawa K, Nakajima Y.
PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis
Cancer Res
2012
72(18):4829-39
PubMed ID: 22826605
DOI: 10.1158/0008-5472.CAN-12-0328
|
|
18250
Xu H, Inagaki Y, Seyama Y, Du G, Wang F, Kokudo N, Tang W.
Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis
Oncol Rep
2011
26(2):371-6
PubMed ID: 21617869
DOI: 10.3892/or.2011.1315
|
|
7643
Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
Br. J. Cancer
2011
105:1733-40
PubMed ID: 22045190
DOI: 10.1038/bjc.2011.453
|
|
7858
Xu H, Inagaki Y, Seyama Y, Hasegawa K, Sugawara Y, Du G, Wang F, Tang W, Kokudo N.
Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression.
Life Sci.
2011
88:1063-9
PubMed ID: 21466814
DOI: 10.1016/j.lfs.2011.03.021
|
|
7928
Shoji Y, Miyamoto M, Ishikawa K, Yoshioka T, Mishra R, Ichinokawa K, Matsumura Y, Itoh T, Shinohara T, Hirano S, Kondo S.
The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.
J Surg Oncol
2011
103:230-8
PubMed ID: 21337550
DOI: 10.1002/jso.21812
|
|
7984
Tomita Y, Imai K, Senju S, Irie A, Inoue M, Hayashida Y, Shiraishi K, Mori T, Daigo Y, Tsunoda T, Ito T, Nomori H, Nakamura Y, Kohrogi H, Nishimura Y.
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
Cancer Sci.
2011
102:697-705
PubMed ID: 21231984
DOI: 10.1111/j.1349-7006.2011.01865.x
|
|
3711
Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H.
Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.
Cancer Sci
2011
102(2):407-13
PubMed ID: 21166957
DOI: 10.1111/j.1349-7006.2010.01808.x
|
|
12860
Trono JD, Mizuno K, Yusa N, Matsukawa T, Yokoyama K, Uesaka M.
Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to X-Ray Drug Delivery System
J Radiat Res
2011
52(1):103-9.
PubMed ID: 21187668
DOI: 10.1269/jrr.10068
|
|
15725
Inaguma S, Kasai K, Ikeda H.
GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin
Oncogene
2011
30(6):714-23
PubMed ID: 20972463
DOI: 10.1038/onc.2010.459
|
|
16753
Arai MA, Tateno C, Koyano T, Kowithayakorn T, Kawabe S, Ishibashi M.
New hedgehog/GLI-signaling inhibitors from Adenium obesum
Org Biomol Chem
2011
9(4):1133-9
PubMed ID: 21170436
DOI: 10.1039/c0ob00677g
|
|
8292
Iseki H, Takeda A, Andoh T, Takahashi N, Kurochkin IV, Yarmishyn A, Shimada H, Okazaki Y, Koyama I.
Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/beta-catenin signaling.
Cancer Sci.
2010
101:1361-6
PubMed ID: 20398052
DOI: 10.1111/j.1349-7006.2010.01541.x
|
|
8294
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.
World J. Gastroenterol.
2010
16:1854-8
PubMed ID: 20397262
DOI: 10.3748/wjg.v16.i15.1854
|
|
5875
Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.
Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Int J Oncol
2009
34(5):1231-40
PubMed ID: 19360336
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18417
Hosoya T, Arai MA, Koyano T, Kowithayakorn T, Ishibashi M.
Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription
Chembiochem
2008
9(7):1082-92
PubMed ID: 18357592
DOI: 10.1002/cbic.200700511
|
|
12297
Michiko Harao, Shinya Hirata, Atsushi Irie, Satoru Senju, Tetsuya Nakatsura, Hiroyuki Komori, Yoshiaki Ikuta, Kazunori Yokomine, Katsunori Imai, Mitsuhiro Inoue, Kumiko Harada, Takeshi Mori, Takuya Tsunoda, Shuichi Nakatsuru, Yataro Daigo, Hiroaki Nomori, Yusuke Nakamura, Hideo Baba, Yasuharu Nishimura
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL
Int J Cancer
2008
123(11):2616-25
PubMed ID: 18770861
DOI: 10.1002/ijc.23823
|
|
19087
Suzuki T, Lu J, Zahed M, Kita K, Suzuki N.
Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells
Arch Biochem Biophys
2007
468(1):1-14
PubMed ID: 17936241
DOI: 10.1016/j.abb.2007.09.004
|
|
15602
Guleng B, Tateishi K, Ohta M, Asaoka Y, Jazag A, Lin LJ, Tanaka Y, Tada M, Seto M, Kanai F, Kawabe T, Omata M.
Smoothened gene mutations found in digestive cancer have no aberrant Hedgehog signaling activity
J Gastroenterol
2006
41(12):1238-9
PubMed ID: 17287906
DOI: 10.1007/s00535-006-1955-2
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
